🕵️ Cardiff Oncology, Inc. ($CRDF)
SEC insider & ownership activity, last 12 months · CIK 1213037 · every row links its SEC filing
Over the last 12 months insiders bought $1.8M with no open-market selling against it. Gary W. Pace bought $1.7M (Jul–Jul). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $1.8M (8 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Gary W. Pace | 5 | $1.7M | 0 | – | Jul 14, 2026 |
| Mohindru Mani | 3 | $80K | 0 | – | Jul 14, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | exited | 13G | Jul 27, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 14, 2026 | filing ↗ |
| Other events (8.01) | Jul 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 14, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 3, 2026 | filing ↗ |
| Material agreement (1.01) | May 27, 2026 | filing ↗ |
| Other events (8.01) | May 19, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 6, 2026 | filing ↗ |
| Other events (8.01) | Apr 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 6, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Feb 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 27, 2026 | filing ↗ |
| Other events (8.01) | Jan 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 27, 2026 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |